Surrozen Warrant Financials

SRZNW Stock  USD 0.05  0.01  28.21%   
Based on the key indicators related to Surrozen Warrant's liquidity, profitability, solvency, and operating efficiency, Surrozen Warrant is not in a good financial situation at this time. It has a very high odds of going through financial crisis in February. At this time, Surrozen Warrant's Capital Lease Obligations is fairly stable compared to the past year. Net Invested Capital is likely to climb to about 54.2 M in 2025, whereas Property Plant And Equipment Net is likely to drop slightly above 3.3 M in 2025. Key indicators impacting Surrozen Warrant's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Debt Equity Ratio0.170.1
Way Up
Slightly volatile
Current Ratio7.996.62
Fairly Up
Pretty Stable
The essential information of the day-to-day investment outlook for Surrozen Warrant includes many different criteria found on its balance sheet. An individual investor should monitor Surrozen Warrant's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Surrozen Warrant.

Net Income

(40.67 Million)

  
Please note, the imprecision that can be found in Surrozen Warrant's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Surrozen Warrant. Check Surrozen Warrant's Beneish M Score to see the likelihood of Surrozen Warrant's management manipulating its earnings.

Surrozen Warrant Stock Summary

Surrozen Warrant competes with Surrozen, Quantum Si, and Humacyte. Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. The company was founded in 2016 and is headquartered in South San Francisco, California. Consonance-Hfw Acq operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CUSIP86889P117 G2445M111
LocationCalifornia; U.S.A
Business Address171 Oyster Point
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.surrozen.com
Phone650 489 9000
CurrencyUSD - US Dollar

Surrozen Warrant Key Financial Ratios

Surrozen Warrant Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets62.1M137.2M89.4M46.1M53.0M83.0M
Other Current Liab3.4M6.5M4.6M4.1M4.7M4.7M
Net Debt(25.4M)(25.3M)(19.1M)(32.7M)(29.4M)(30.9M)
Retained Earnings(88.0M)(142.6M)(178.7M)(221.7M)(199.5M)(209.5M)
Accounts Payable1.8M2.7M658K525K472.5K448.9K
Cash35.0M33.1M24.7M36.0M41.4M34.7M
Other Current Assets1.0M6.7M4.6M2.9M3.4M3.4M
Total Liab14.8M27.5M13.4M8.1M7.3M12.3M
Total Current Assets50.2M105.2M81.3M41.1M47.3M67.6M

Surrozen Warrant Key Income Statement Accounts

The reason investors look at the income statement is to determine what Surrozen Warrant's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
202020212022202320242025 (projected)
Operating Income(32.8M)(54.4M)(44.3M)(45.8M)(41.2M)(43.3M)
Ebit(34.3M)(54.4M)(44.3M)(43.0M)(38.7M)(40.7M)
Research Development25.7M40.2M37.0M27.2M31.3M32.9M
Ebitda(31.4M)(52.3M)(42.4M)(41.1M)(37.0M)(38.9M)
Income Before Tax(32.7M)(54.6M)(36.0M)(43.0M)(38.7M)(40.7M)
Net Income(32.6M)(52.5M)(27.7M)(43.0M)(38.7M)(40.7M)

Surrozen Warrant Key Cash Accounts

202020212022202320242025 (projected)
Change In Cash5.9M(1.9M)(8.4M)11.6M10.5M5.9M
Free Cash Flow(30.0M)(50.1M)(44.9M)(40.8M)(36.7M)(38.5M)
Depreciation1.9M2.1M2.0M1.9M1.7M1.6M
Other Non Cash Items992K1.2M(6.2M)325K292.5K307.1K
Capital Expenditures874K1.3M728K398K358.2K340.3K
Net Income(32.7M)(54.6M)(36.0M)(43.0M)(38.7M)(40.7M)
End Period Cash Flow35.4M33.5M25.1M36.7M42.2M35.2M

Surrozen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Surrozen Warrant's current stock value. Our valuation model uses many indicators to compare Surrozen Warrant value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surrozen Warrant competition to find correlations between indicators driving Surrozen Warrant's intrinsic value. More Info.
Surrozen Warrant is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . At this time, Surrozen Warrant's Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Surrozen Warrant by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Surrozen Warrant Systematic Risk

Surrozen Warrant's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Surrozen Warrant volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Surrozen Warrant correlated with the market. If Beta is less than 0 Surrozen Warrant generally moves in the opposite direction as compared to the market. If Surrozen Warrant Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Surrozen Warrant is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Surrozen Warrant is generally in the same direction as the market. If Beta > 1 Surrozen Warrant moves generally in the same direction as, but more than the movement of the benchmark.

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Surrozen Warrant is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Surrozen has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Surrozen Warrant's financials are consistent with your investment objective using the following steps:
  • Review Surrozen Warrant's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Surrozen Warrant's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Surrozen Warrant's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Surrozen Warrant's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Surrozen Warrant Thematic Clasifications

Surrozen Warrant is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Pharmaceutical ProductsView
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Surrozen Warrant Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Surrozen Warrant's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Surrozen Warrant growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(0.006134)

At this time, Surrozen Warrant's Price Earnings To Growth Ratio is fairly stable compared to the past year.

Surrozen Warrant January 19, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Surrozen Warrant help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Surrozen Warrant. We use our internally-developed statistical techniques to arrive at the intrinsic value of Surrozen Warrant based on widely used predictive technical indicators. In general, we focus on analyzing Surrozen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Surrozen Warrant's daily price indicators and compare them against related drivers.

Additional Tools for Surrozen Stock Analysis

When running Surrozen Warrant's price analysis, check to measure Surrozen Warrant's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surrozen Warrant is operating at the current time. Most of Surrozen Warrant's value examination focuses on studying past and present price action to predict the probability of Surrozen Warrant's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surrozen Warrant's price. Additionally, you may evaluate how the addition of Surrozen Warrant to your portfolios can decrease your overall portfolio volatility.